25,078 press releases indexed under finance.
BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases, today announced that members of Zevra’s executive leadership team will present at the following investor conferences in New York, NY.
PARSIPPANY, N.J., September 02, 2026--Zoetis Inc. (NYSE:ZTS) today announced that Kristin Peck, Chief Executive Officer, and Jay Saccaro, EVP, Chief Financial Officer and Chief Operating Officer, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026 at 1:50 p.m. ET.
REHOVOT, Israel, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or the “Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing a next-generation immunotherapy platform designed to maximize anti-cancer activity while minimizing toxicity, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application covering tri-specific antibody constructs and methods of use. The patent allowance further expands the Company's intellectual property portfolio supporting its proprietary CAPTN-3 platform for conditionally activated multispecific antibodies.
WAYNE, Pa., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc . (Palvella or the “Company”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies for serious, rare skin diseases and vascular malformations for which there are no U.S. Food and Drug Administration (FDA)-approved therapies, today announced that Wes Kaupinen, Founder and Chief Executive Officer of Palvella, will participate in two upcoming healthcare investor conferences.
Former Israeli Consulate Economic Affairs Officer in Dubai, Founder of Israel’s Economic Division in the UAE Following the Abraham Accords, and Arabic-Speaking IDF Intelligence Analyst to Drive Government and Sovereign Engagement Across the GCC as Quantum Cyber Advances Its Israel-to-U.S. Battlefield-Proven Defense Technology Strategy Former Israeli Consulate Economic Affairs Officer in Dubai, Founder of Israel’s Economic Division in the UAE Following the Abraham Accords, and Arabic-Speaking IDF Intelligence Analyst to Drive Government and Sovereign Engagement Across the GCC as Quantum Cyber Advances Its Israel-to-U.S. Battlefield-Proven Defense Technology Strategy
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Intuit Inc. (NASDAQ:INTU) securities. If you suffered a loss on your Intuit Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Intuit Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Intuit Inc. that ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) securities. If you suffered a loss on your Regeneron investment and would like to explore a potential recovery under the federal securities laws, Learn about Regeneron Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Regeneron Pharmaceuticals, Inc. that ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Megan Holdings Limited (NASDAQ:MGN) securities. If you suffered a loss on your Megan investment and would like to explore a potential recovery under the federal securities laws, Learn about Megan Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: This lawsuit is on behalf of persons and entities that purchased or ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Replimune Group, Inc. (NASDAQ:REPL) securities. If you suffered a loss on your Replimune Group, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Replimune Group, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired iTonic Holdings Ltd. f/k/a Pheton Holdings Ltd. (NASDAQ:ITOC) securities. If you suffered a loss on your iTonic Holdings Ltd. f/k/a Pheton Holdings Ltd. investment and would like to explore a potential recovery under the federal securities laws, Learn about iTonic Holdings Ltd. f/k/a Pheton Holdings Ltd. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of ..
(PR-inside.com) NEWARK, CA / ACCESS Newswire / September 2, 2026 / Protagonist Therapeutics (NASDAQ:PTGX) ("Protagonist" or "the Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in two investment bank conferences taking place in September 2026. Citi Biopharma Back to School Conference; New York, NY - September 9-10, 2026 Format: Fireside ChatDay/Time: Wednesday, September 9 at 10:40 A.M. ETWebcast: HERE 2026 Cantor Global Healthcare Conference; New York, NY - September 9-11, 2026 Format: Fireside ChatDay/Time: Thursday, September 10 at 10:20 A.M. ETWebcast: HERE If you are interested in meeting with the Protagonist team during the conferences, please reach out to ..
NASDAQ | TSX: ACB Curaleaf's hostile and opportunistic bid significantly undervalues Aurora, and aims to capture Aurora's assets at a discount Aurora is debt free and holds $149 million in cash1, Curaleaf carries over $1 billion in debt2, Aurora shareholders' own cash should not be used...